These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37552777)

  • 21. Obesity, obesities and gastrointestinal cancers.
    Zou Y; Pitchumoni CS
    Dis Mon; 2023 Dec; 69(12):101592. PubMed ID: 37308362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Obesity and Colorectal Cancer].
    Lee J; Kim SY
    Korean J Gastroenterol; 2023 Aug; 82(2):63-72. PubMed ID: 37621241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Obesity as a factor in the development of cancer in type 2 diabetes].
    Łukasiewicz D; Chodorowska M; Jakubowska I
    Pol Merkur Lekarski; 2015 Mar; 38(225):135-9. PubMed ID: 25815612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma.
    Fukushima H; Masuda H; Yokoyama M; Tatokoro M; Yoshida S; Ishioka J; Matsuoka Y; Numao N; Koga F; Saito K; Fujii Y; Kihara K
    Jpn J Clin Oncol; 2013 Jul; 43(7):740-6. PubMed ID: 23729495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged Nightly Fasting and Breast Cancer Prognosis.
    Marinac CR; Nelson SH; Breen CI; Hartman SJ; Natarajan L; Pierce JP; Flatt SW; Sears DD; Patterson RE
    JAMA Oncol; 2016 Aug; 2(8):1049-55. PubMed ID: 27032109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity.
    Zhu Z; Wong SYS; Sung JJY; Lam TYT
    Curr Diab Rep; 2023 Oct; 23(10):253-263. PubMed ID: 37535293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.
    Asmar R; Beebe-Dimmer JL; Korgavkar K; Keele GR; Cooney KA
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):62-6. PubMed ID: 22907512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49).
    Schrijnders D; Hendriks SH; Kleefstra N; Vissers PAJ; Johnson JA; de Bock GH; Bilo HJG; Landman GWD
    PLoS One; 2018; 13(1):e0190870. PubMed ID: 29370205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of obesity in colorectal carcinogenesis].
    Hagymási K; Tulassay Z
    Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet.
    Spallone V
    Diabetes Metab J; 2019 Feb; 43(1):3-30. PubMed ID: 30793549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population.
    Lazo M; Nwankwo C; Daya NR; Thomas DL; Mehta SH; Juraschek S; Willis K; Selvin E
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1957-1964.e7. PubMed ID: 28579183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer.
    Ferguson RD; Gallagher EJ; Scheinman EJ; Damouni R; LeRoith D
    Vitam Horm; 2013; 93():51-98. PubMed ID: 23810003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study.
    Stürmer T; Buring JE; Lee IM; Gaziano JM; Glynn RJ
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2391-7. PubMed ID: 17164361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses.
    Shim HJ; Lee R; Shin MH; Kim HN; Kweon SS
    Cancer Epidemiol; 2016 Dec; 45():108-111. PubMed ID: 27792933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity, type 2 diabetes and risk of digestive cancer.
    Hillon P; Guiu B; Vincent J; Petit JM
    Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic risk factors of ovarian cancer: a review.
    Khanlarkhani N; Azizi E; Amidi F; Khodarahmian M; Salehi E; Pazhohan A; Farhood B; Mortezae K; Goradel NH; Nashtaei MS
    JBRA Assist Reprod; 2022 Apr; 26(2):335-347. PubMed ID: 34751020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in type 2 diabetes.
    Kautzky-Willer A; Leutner M; Harreiter J
    Diabetologia; 2023 Jun; 66(6):986-1002. PubMed ID: 36897358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interplay between muscle mass decline, obesity, and type 2 diabetes.
    Maliszewska K; Adamska-Patruno E; Krętowski A
    Pol Arch Intern Med; 2019 Nov; 129(11):809-816. PubMed ID: 31617855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and diabetes as prognostic factors in patients with colorectal cancer.
    Voutsadakis IA
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S109-S114. PubMed ID: 27989518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.